We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Inova Lands $50M Gift for Personalized Oncology Research
News

Inova Lands $50M Gift for Personalized Oncology Research

Inova Lands $50M Gift for Personalized Oncology Research
News

Inova Lands $50M Gift for Personalized Oncology Research

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Inova Lands $50M Gift for Personalized Oncology Research"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Inova recently announced a $50 million gift from Dwight Schar to launch a new oncology research institute at the Inova Center for Personalized Health in Fairfax, Virginia.

Donald "Skip" Trump will lead the cancer institute as CEO and executive director, Inova said. 

The Inova Center for Personalized Health is part of the Inova Health System, a non-profit healthcare provider in Northern Virginia and the Washington, DC metro area. The Inova Translational Medicine Institute is also a part of the Inova system.

In a separate statement, the Fairfax County Economic Development Authority said that the new institute has as its goal, the creation of a leading center for translational cancer research and patient care based on genomics and individualized therapy. Researchers at the institute will develop new genomics-based tests, therapies, and population health processes. The institute will also collaborate with life science firms, resulting in the expansion of the life science economy in the Virginia and Washington region.

In April 2014, Inova announced it planned to offer whole-genome sequencing by prescription for sick newborns.

Advertisement